Key result
A lymphangitic carcinomatosis perfusion pattern on scintigraphic imaging was associated with a progressive course in 79% of patients, with 67% of those with known survival intervals dying within one month.
Why the study?
What is the prognostic implication of a lymphangitic carcinomatosis pattern on a perfusion lung scan?
What is the prognostic implication of a lymphangitic carcinomatosis pattern on a perfusion lung scan?
A lymphangitic carcinomatosis pattern on perfusion lung scan is associated with a rapid progressive course and poor short-term survival.
May signal rapid decline and short survival; hypothesis-generating and requires prospective validation before informing care.
PURPOSE: Findings not associated with thromboembolic disease on routine perfusion lung scan may sometimes have particular clinical significance. We wanted to assess the clinical importance and overall survival after the recognition of a lymphangitic carcinomatosis pattern on perfusion lung scan. CASE REPORT: We report a case of lymphangitic carcinomatosis pattern on perfusion lung scan performed in a previously healthy patient who had rapid progressive course and died the next day. METHOD: A Medline search of case reports that describes either lymphangitic carcinomatosis or tumour microemboli on perfusion lung scan. RESULTS: There were a total of 32 patients identified in 21 articles from various countries, including our case. The studied perfusion pattern was reported more often in female patients (81%) was associated with a progressive history of dyspnea (69%) and normal or mild findings on chest radiograph (58%). Of the 29 patients with available outcome data, 79% (23/29) had a progressive course after the lung scan interpretation. In 18 of these 23 cases, the actual interval of survival was given: 67% of these patients (12/18) died within the first month. DISCUSSION: A lymphangitic carcinomatosis perfusion pattern on scintigraphic imaging is associated with a poor prognosis. Nuclear medicine physicians should be aware of this association and that raising the suspicion for a metastatic process may make a difference in the treatment plan of these patients.
No takes yet. Share an insight, caveat, or question.
Charest et al. (2011) conducted a review in Lymphangitic carcinomatosis pattern on perfusion lung scan (n=32). Lymphangitic carcinomatosis pattern on perfusion lung scan was evaluated on Progressive course after lung scan interpretation. A lymphangitic carcinomatosis perfusion pattern on scintigraphic imaging was associated with a progressive course in 79% of patients, with 67% of those with known survival intervals dying within one month.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: